Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy
Junko Haraga(Okayama University), Yuji Hiramatsu(University of Tsukuba), Hisashi Masuyama(Okayama University), Tomoko Haruma(Okayama University), Keiichiro Nakamura, Norihisa Katayama(Okayama University), Noriko Seki(Okayama University), Takeshi Nishida(Osaka Prefectural Medical Center), Tomoyuki Kusumoto(Okayama University), Susumu Kanazawa(Okayama University), Chiaki Omichi(Okayama University)
Cited by 79
Related Papers
Accurate diagnosis of musculoskeletal lesions by core needle biopsy
|Journal of Surgical Oncology|2006|162
Analysis of Factors Associated With Radiation-Induced Bronchiolitis Obliterans Organizing Pneumonia Syndrome After Breast-Conserving Therapy
|International Journal of Radiation Oncology*Biology*Physics|2008|69
Post‐intensive care syndrome: Recent advances and future directions
|Acute Medicine & Surgery|2024|64
Urinary and Rectal Toxicity Profiles After Permanent Iodine-125 Implant Brachytherapy in Japanese Men: Nationwide J-POPS Multi-institutional Prospective Cohort Study
|International Journal of Radiation Oncology*Biology*Physics|2015|43
Sarcopenia Is an Important Prognostic Factor in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy
|International Journal of Gynecological Cancer|2017|43